These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9580110)

  • 21. Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-beta HDL containing apolipoprotein A-II.
    Pastier D; Dugué S; Boisfer E; Atger V; Tran NQ; van Tol A; Chapman MJ; Chambaz J; Laplaud PM; Kalopissis AD
    Biochemistry; 2001 Oct; 40(41):12243-53. PubMed ID: 11591143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.
    Föger B; Chase M; Amar MJ; Vaisman BL; Shamburek RD; Paigen B; Fruchart-Najib J; Paiz JA; Koch CA; Hoyt RF; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 1999 Dec; 274(52):36912-20. PubMed ID: 10601244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
    Hoeg JM; Santamarina-Fojo S; Bérard AM; Cornhill JF; Herderick EE; Feldman SH; Haudenschild CC; Vaisman BL; Hoyt RF; Demosky SJ; Kauffman RD; Hazel CM; Marcovina SM; Brewer HB
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11448-53. PubMed ID: 8876155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
    Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
    Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of human lecithin:cholesterol acyltransferase in mice offers no protection against diet-induced atherosclerosis.
    Mehlum A; Gjernes E; Solberg LA; Hagve TA; Prydz H
    APMIS; 2000 May; 108(5):336-42. PubMed ID: 10937770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesterol 7alpha-hydroxylase influences the expression of hepatic apoA-I in two inbred mouse strains displaying different susceptibilities to atherosclerosis and in hepatoma cells.
    Dueland S; France D; Wang SL; Trawick JD; Davis RA
    J Lipid Res; 1997 Jul; 38(7):1445-53. PubMed ID: 9254069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI.
    Rubin EM; Krauss RM; Spangler EA; Verstuyft JG; Clift SM
    Nature; 1991 Sep; 353(6341):265-7. PubMed ID: 1910153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice.
    Schultz JR; Gong EL; McCall MR; Nichols AV; Clift SM; Rubin EM
    J Biol Chem; 1992 Oct; 267(30):21630-6. PubMed ID: 1400473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative trait locus analysis of susceptibility to diet-induced atherosclerosis in recombinant inbred mice.
    Hyman RW; Frank S; Warden CH; Daluiski A; Heller R; Lusis AJ
    Biochem Genet; 1994 Dec; 32(11-12):397-407. PubMed ID: 7748156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha.
    Mamontova A; Séguret-Macé S; Esposito B; Chaniale C; Bouly M; Delhaye-Bouchaud N; Luc G; Staels B; Duverger N; Mariani J; Tedgui A
    Circulation; 1998 Dec; 98(24):2738-43. PubMed ID: 9851961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase.
    Bérard AM; Föger B; Remaley A; Shamburek R; Vaisman BL; Talley G; Paigen B; Hoyt RF; Marcovina S; Brewer HB; Santamarina-Fojo S
    Nat Med; 1997 Jul; 3(7):744-9. PubMed ID: 9212100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
    Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
    Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice overexpressing human lecithin: cholesterol acyltransferase are not protected against diet-induced atherosclerosis.
    Mehlum A; Muri M; Hagve TA; Solberg LA; Prydz H
    APMIS; 1997 Nov; 105(11):861-8. PubMed ID: 9393557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol homeostatic mechanisms in transgenic mice with altered expression of apoproteins A-I, A-II and A-IV.
    Kalopissis AD; Chambaz J
    Int J Tissue React; 2000; 22(2-3):67-78. PubMed ID: 10937356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
    Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
    J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
    Li H; Reddick RL; Maeda N
    Arterioscler Thromb; 1993 Dec; 13(12):1814-21. PubMed ID: 8241102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.
    Hedrick CC; Castellani LW; Warden CH; Puppione DL; Lusis AJ
    J Biol Chem; 1993 Sep; 268(27):20676-82. PubMed ID: 8376417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice.
    Chiesa G; Parolini C; Canavesi M; Colombo N; Sirtori CR; Fumagalli R; Franceschini G; Bernini F
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1417-23. PubMed ID: 9743230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.